8-K: InnovAge Appoints Michael Scarbrough as President and COO, Maria Lozzano Promoted to President, Pharmacy Services

InnovAge Holding Corp. has appointed Michael Scarbrough as its new President and Chief Operating Officer, and promoted Maria Lozzano to President, Pharmacy Services, effective November 4, 2024.

Summary

• InnovAge Holding Corp. has appointed Michael Scarbrough as President and Chief Operating Officer, effective November 4, 2024.
• Michael Scarbrough replaces Christine Bent, who is stepping down from the COO role to pursue other opportunities.
• Christine Bent will remain with the company as a Senior Advisor until December 31, 2024, to support the transition.
• Patrick Blair, the current CEO, will relinquish the President title but remain as CEO.
• Michael Scarbrough's employment agreement includes an annual base salary of $485,000 and eligibility for a 75% target annual bonus.
• Scarbrough will also receive 1,000,000 Class B Units of TCO Group Holdings, with vesting based on time and performance.
• Maria Lozzano has been promoted to President, Pharmacy Services, reporting directly to the CEO.
• Lozzano previously served as Senior Vice President and Chief Business Development Operations Officer.
• InnovAge served approximately 7,020 participants across 20 centers in six states as of June 30, 2024.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting new leadership appointments and strategic changes. However, there is a mention of a COO departure, which could introduce some uncertainty. Overall, the sentiment is moderately positive.

Positives

• Michael Scarbrough brings over 30 years of healthcare experience, including executive operational leadership and government programs expertise.
• Maria Lozzano's promotion to President, Pharmacy Services, recognizes her strong contributions and leadership within the company.
• The separation of the President and CEO roles is intended to improve strategic execution.
• The company is actively working to improve its pharmacy operating model for better participant experience and cost-effectiveness.

Negatives

• The departure of Christine Bent as COO may cause some disruption during the transition period.
• The company is undergoing a significant leadership change with the appointment of a new President and COO.

Risks

• The company's success depends on the effective transition of leadership and the ability to retain skilled employees.
• Failure to execute an orderly transition of the President and COO roles could negatively impact the company.
• The company's ability to improve and grow is subject to various risk factors, including those identified in their SEC filings.

Future Outlook

The company expects to continue to evolve its business and serve more seniors, with a focus on improving the pharmacy operating model for better participant experience and cost-effectiveness. The company also expects to execute its strategic priorities with the new leadership structure.

Management Comments

• Patrick Blair, CEO, stated that Michael Scarbrough's operational background and healthcare experience is a great fit for InnovAge.
• Blair also expressed gratitude to Christine Bent for her service and contributions.
• Blair noted Maria Lozzano's strong contributions and trust in her ability to lead the pharmacy services.

Industry Context

The appointment of a new President and COO and the promotion of a key executive in pharmacy services reflects a strategic move by InnovAge to strengthen its leadership team and improve operational efficiency in the competitive healthcare industry, particularly within the Program of All-inclusive Care for the Elderly (PACE) sector. This is a common practice in the industry to bring in new talent and expertise to drive growth and improve performance.

Comparison to Industry Standards

• The appointment of a new COO and the promotion of a key executive are common practices in the healthcare industry to drive growth and improve performance.
• Michael Scarbrough's experience at Optum at Home and Prospero Health aligns with the industry trend of focusing on home-based care models.
• The separation of the President and CEO roles is a strategic move to improve focus and execution, which is also seen in other large healthcare organizations.
• The focus on improving the pharmacy operating model is consistent with the industry's emphasis on cost-effectiveness and participant experience.

Management Changes

Stakeholder Impact

• Shareholders may react positively to the new leadership appointments and strategic changes.
• Employees may experience some changes during the leadership transition.
• Participants may benefit from the company's focus on improving the pharmacy operating model.
• Suppliers may need to adjust to new leadership and operational changes.

Next Steps

• Michael Scarbrough will assume his role as President and COO on November 4, 2024.
• Christine Bent will transition to a Senior Advisor role until December 31, 2024.
• Maria Lozzano will begin her role as President, Pharmacy Services, reporting to the CEO.
• The company will continue to execute its strategic priorities with the new leadership structure.

Key Dates

Keywords

InnovAge, Michael Scarbrough, Maria Lozzano, President, Chief Operating Officer, Pharmacy Services, PACE, healthcare, executive leadership, senior care